Sheetal Kumar

Sheetal Kumar is a Senior Scientist at Nimbus Therapeutics since January 2020, with extensive experience in drug safety profiling and assay development, including managing in vitro predictive safety profiling across various therapeutic areas. Previous roles include Senior Associate Scientist at Amgen, where efforts focused on developing cell-based models for drug safety investigation, and positions at Pfizer, the National Institutes of Health, and the University of Cambridge, contributing to research in heart failure, vascular disease, and nuclear-cytoplasmic transport. Sheetal holds Master's degrees in Bioanalytical & Clinical Chemistry and Chemistry, as well as a Bachelor's degree in Chemistry and a Certificate in Level 3 Line Management from the University of Cambridge.